Lakefront Biotherapeutics NV ADR (LKFT) Straddle

Trading a LKFT straddle lets you take a pure volatility position on Lakefront Biotherapeutics NV ADR without committing to a direction. Lakefront Biotherapeutics NV ADR's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate LKFT straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on LKFT profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Lakefront Biotherapeutics NV ADR stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the LKFT straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Galapagos NV is a biotechnology company that specializes in the discovery and advancement of novel small molecule and antibody-based therapeutics. Its active clinical development programs include drugs like filgotinib and GLP3667, alongside the Toledo program and therapies targeting idiopathic pulmonary fibrosis. The firm was established on June 30, 1999, by co-founders Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es, and maintains its headquarters in Mechelen, Belgium.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the LKFT straddle is the cleanest expression of that view. Our scanner prices every LKFT straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a LKFT straddle into a catalyst or short a LKFT straddle to harvest decay, the options straddle setups that matter are all in one place.